state-enforcement

manilatimes.net

Made-in-China Agrees to Stop Selling GLP-1 Compounds in U.S., Pays $30,000 Penalty to Connecticut

The international online platform agreed to halt all sales of GLP-1 medications to U.S. customers and pay a suspended $300,000 penalty. Connecticut Attorney General William Tong said the drugs contained impurities and inconsistent active ingredients with no generic versions legal…